期刊文献+

福建省2009年甲型H1N1流感病毒NA基因特征及对达菲的耐药性 被引量:4

Preliminary study on characteristics of NA genes and oseltamivir resistance in 2009 pandemic H1N1 influenza viruses in Fujian,China
暂未订购
导出
摘要 目的监测福建省甲型H1N1流感病毒NA基因的变化以及对达菲的耐药情况,为临床诊疗和疾病控制提供参考依据。方法从福建省流感监测网络中随机选取23株甲型H1N1流感病毒,经病毒核酸提取和一步法RT-PCR扩增,获得NA基因片段,双向测定核苷酸序列,分析NA基因序列和重要氨基酸位点特征。结果 23株甲型H1N1流感病毒NA片段基因与A/California/07/2009(H1N1)代表株的核苷酸序列进行比较,同源性高达98.1%以上;23株毒株NA蛋白第275位氨基酸均为组氨酸。结论随机选取的23株甲型H1N1流感病毒NA基因片段保持高度同源并且对达菲仍然敏感。随着国内外达菲耐药株的不断出现,应加强耐药性监测,为制定应对甲型H1N1流感流行措施提供参考。 To investigate characteristics of NA genes and oseltamivir susceptibility of 2009 pandemic H1N1 influenza viruses in Fujian Province, twenty-three strains were randomly selected for detection. Fragments of NA genes were amplified by one-step RT-PCR and then were sequenced. Comparing with the A/California/OT/2OO9(H1N1), alignment of nucleic acid sequences revealed a high homology of 98.1%. While the amino acid residuals at 275 remained histidine, indicating all of the 23 isolates were oseltamivir-sensitive. This observation suggests no oseltamivir-resistant strains has emerged in Fujian. However, continuous surveillance is necessary for control and prevention strategies of the ongoing pandemic.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2010年第10期904-906,911,共4页 Chinese Journal of Zoonoses
基金 国家传染病防治科技重大专项"突发传染病病原体快速检测与现场机动采样技术平台研究"(2009ZX10004-106)资助
关键词 2009甲型H1N1流感病毒 NA基因特征 达菲耐药性 2009 pandemic H1N1 influenza viruses characteristic of NA oseltamivir-resistant
  • 相关文献

参考文献11

  • 1Johnson NP,Mueller J.Updating the accounts:global mortality of the 1918-1920"Spanish"influenza pandemic[J].Bull Hist Med,2002,76(1):105-115.
  • 2McHardy AC,Adams B.The role of genomics in tracking the evolution of influenza A virus[J].PLoS Pathog,2009,5 (10):e1000566.
  • 3Smith GJ,Vijaykrishna D,Bahl J,et al.Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic[J].Nature,2009,459(7250):1122-1125.
  • 4谢剑锋,沈晓娜,王美爱,张拥军,吴冰珊,陈炜,王金章,修文琼,朱莉莉,杨式芹,陈端,翁育伟,郑奎城,严延生.福建省甲型H1N1流感病毒分离及首例分离株全基因组序列分析[J].中国人兽共患病学报,2009,25(8):745-748. 被引量:18
  • 5Bright RA,Shay DK,Shu B,et al.Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States[J].JAMA,2006,295(8):891-894.
  • 6蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 7杜宁,王大燕,舒跃龙.2009新甲型H1N1流感病毒病原学概述[J].病毒学报,2009,25(6):479-484. 被引量:27
  • 8Zonis Z,Engelhard D,Hindiyeh M,et al.Community-acquired oseltamivir-resistant pandemic (H1N1) 2009 in child,Israel[J].Emerg Infect Dis,2010,16(6):1045-1046.
  • 9Colman PM,Hoyne PA,Lawrence MC.Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase[J].J Virol,1993,67(6):2972-2980.
  • 10Ferraris O,Lina B.Mutations of neuraminidase implicated in neuraminidase inhibitors resistance[J].J Clin Virol,2008,41(1):13-19.

二级参考文献66

  • 1WHO. Pandemic (HIN1) 2009-update 57[EB/OL]. http:// www. who. int/csr/don/2009/07/03/en/index, html.
  • 2Ron Fouchier A M, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemmagglutinin subtype (H16) obtained from black headed gulls[J]. J Virol, 2005,79 (5) :2814-2822.
  • 3Qi X, Pang B, Lu C P. Genetic characterization of H1N1 swine influenza A virus isolated in eastern China [J]. Virus Genes, 2009, doi : 10. 1007/s11262-009-0375-9.
  • 4WHO. Viral gene sequences to assist update diagnostics for swine influenza A( H1 N1 )[EB/OL]. http://www, emro. who. int/arabic/csr/hl nl/pdf/hlnl_viralgene, pdf.
  • 5Dawood FS, Jain S, Finelli L,et al. Emergence of a novel swine --origin influenza A (H1N1) virus in humans[J]. N Engl J Med,2009, 360(25) :2605- 15.
  • 6Smith GJ, Vijaykrishna D, Bahl J. Origins and evolutionary genomics of the 2009 swine origin H1N1 influenza A epidemie[J]. Nature, 2009,Jun 25.459(7250):1122-5.
  • 7WHO. Sequencing primers and protocol[EB/OL], http:// www. who. int/csr/resources/publications/swineflu/GenomePrimers_20090512, pdf.
  • 8Reid A H, Janezewski T A, Lourens R M, et al. 1918 influenza pandemic caused by highly conserved viruses with two receptorbinding variants[J]. Emerg Infect Dis, 2003, 9:1249-1253.
  • 9IvesJ A L, CarrJ A, MendelDB,et al. The H274Ymutation in the influenza A/ H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo [J]. Antivir Res, 2002, 55: 307 -317.
  • 10舒跃龙.新A(H1N1)病毒疫情及病原学概述[C].全国新甲型H1N1防控培训,2009.5.

共引文献66

同被引文献74

  • 1蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 2张庆宏,杨进,龚婕宁,郭海.连花清瘟胶囊对内毒素致热家兔体温的影响[J].辽宁中医药大学学报,2007,9(1):44-45. 被引量:14
  • 3莫红缨,柯昌文,郑劲平,钟南山.连花清瘟胶囊体外抗甲型流感病毒的实验研究[J].中药新药与临床药理,2007,18(1):5-9. 被引量:108
  • 4World Health Organization.WHO information for molecular diagnosis of influenza virus in humans-update [EB/OL].http://www.who.int/influenza/resources/documents/molecular_diagnosis_influenza_virus_humans_update 201108.pdP.ua= 1.
  • 5Hay AJ,Zambon MC,Wolstenhohne AJ,et al.Molecular basis of resistance of influenza A viruses to amantadine [J].J Antimicrob Chemother,1986,18(SupplB):19-29.
  • 6Cochran KW,Maassab HF,Tsunoda A,et al.Studies on the an-tiviral activity of amantadine hydrochloride [J ].Ann N Y Aead Sci,1965,130(1):432-43.
  • 7Hayden FG.Prevention and treatment of influenza in immunoeompro-mised patients [J].J Med,1997,102(3A):55-60;discussion 75-6.
  • 8Gubareva LV,Matrosovich MN,Brenner MK,et al.Evidence for zanamivir resistance in an immunocompremised child infected with influenzaB virus[J].Infect Dis,1998,178(5):1257-1262.
  • 9Wang C,Takeuchi K,Pinto LH,et al.Ion channel activity of in-fluenza A virus M2 protein:characterization of the amantadine block [J].J Virol,1993,67(9):5585-5594.
  • 10Colman PM,Varghese JN,Laver WG.Structure of the catalytic and antigenic sites in influenza virus neuraminidase [J].Nature,1983,303(5912):41-44.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部